Clinical Trials Browser

OTHER × Squamous Cell Carcinoma of Head and Neck × anlotinib × Clear all

NCT06699498 2024-11-21

Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck